Results of superior vena cava resection for lung cancer - Analysis of prognostic factors

被引:60
作者
Spaggiari, L
Magdeleinat, P
Kondo, H
Thomas, P
Leon, ME
Rollet, G
Regnard, JF
Tsuchiya, R
Pastorino, U
机构
[1] European Inst Oncol, Dept Thorac Surg, I-20141 Milan, Italy
[2] Hop Hotel Dieu, Dept Thorac Surg, F-75181 Paris, France
[3] Natl Canc Ctr, Dept Thorac Surg, Tokyo 104, Japan
[4] St Marguerite Univ Hosp, Dept Thorac Surg, Marseille, France
[5] European Inst Oncol, Dept Biostat, Milan, Italy
关键词
lung cancer; superior vena cava; surgery; extended resection; T4; mediastinal surgery; vascular surgery;
D O I
10.1016/j.lungcan.2003.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The benefits of superior vena cava (SVC) resection for lung cancer remain controversial. Data obtained in four international centers were analyzed in order to identify prognostic factors and thus guide in future patient selection. Materials and methods: Retrospective study. Prognostic factors were examined by logistic regression for postoperative morbidity/mortality using the Kaplan-Meier method (log rank test) and the Cox proportional-hazard model for survival. Results: From 1963 to 2000, 109 patients underwent SVC resection. Induction treatment was given to 23 (21%) patients. The SVC was resected for T involvement in 78 (72%) cases and for N involvement in 31 (28%) cases. Fifty-five (50.5%) patients underwent pneumonectomy (20 with carinal resection), while the remaining underwent lobar resections. Prosthetic SVC replacement was performed in 28 (26%) patients; partial resection with running suture (53%), vascular stapler (13%), or patch (7%) was performed in 80 patients; 1 patient did not undergo reconstruction. Pathological examination identified direct involvement (T4) in 66 (60%) patients and N2 disease in 55 (50%) patients. Major postoperative morbidity and mortality were 30 and 12%, respectively. Median intensive care unit stay was 3 days, while median hospital stay was 16 days. Five-year survival was at 21%, with median survival at 11 months. In multiple regression analysis, induction treatment was associated with an increased risk of major complications (P = 0.016). None of the factors assessed demonstrated an association with postoperative death. In multivariate survival analysis, both pneumonectomy and complete resection of the SVC with prosthetic replacement were associated with a significant increased risk of death (P = 0.0013 and 0.014, respectively). Conclusions: The radical resection of lung cancer involving the SVC may result in a permanent cure in carefully selected patients. The type of pulmonary resection (i.e., pneumonectomy) and the type of SVC resection (i.e., complete resection with prosthetic replacement) are the prognostic factors with the greatest adverse effect on survival. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [21] 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer
    Shargall, Y
    de Perrot, M
    Keshavjee, S
    Darling, G
    Ginsberg, R
    Johnston, M
    Pierre, A
    Waddell, TK
    LUNG CANCER, 2004, 45 (03) : 357 - 363
  • [22] Superior Vena Cava Resection in Locally Advanced Thymoma-Surgical and Survival Outcomes
    Kumar, Arvind
    Pulle, Mohan Venkatesh
    Bin Asaf, Belal
    Shivnani, Ganesh
    Maheshwari, Arun
    Kodaganur, Srinivas Gopinath
    Puri, Harsh Vardhan
    Bishnoi, Sukhram
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2020, 11 (04) : 711 - 719
  • [23] Superior and inferior vena cava syndrome caused by a rare lung cancer: A case report
    Joshi, Amey
    Law, Jason
    Shah, Niket
    Ghnaima, Harith
    Akanbi, Maxwell
    Tikaria, Richa
    CLINICAL CASE REPORTS, 2024, 12 (09):
  • [24] Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?
    Sato, Hiroki
    Soh, Junichi
    Hotta, Katsuyuki
    Katsui, Kuniaki
    Kanazawa, Susumu
    Kiura, Katsuyuki
    Toyooka, Shinichi
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 24 (03) : 131 - 138
  • [25] Surgical treatment of lung tumors with superior vena cava infiltration
    Ristanovic, Aleksandar
    Bjelanovic, Zoran
    Kostovski, Vanja
    Maric, Nebojsa
    Vesovic, Natasa
    Denic, Ljubinko
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2018, 146 (1-2) : 73 - 76
  • [26] Gallbladder cancer with tumor thrombus in the superior vena cava
    Batra, Sandeep
    Doval, Dinesh Chandra
    Batra, Ullas
    Suresh, Pandalanghat
    Dhiman, Amit
    Talwar, Vineet
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (03) : 325 - 328
  • [27] Gallbladder cancer with tumor thrombus in the superior vena cava
    Sandeep Batra
    Dinesh Chandra Doval
    Ullas Batra
    Pandalanghat Suresh
    Amit Dhiman
    Vineet Talwar
    Hepatobiliary & Pancreatic Diseases International, 2010, 9 (03) : 325 - 328
  • [28] Left upper lung cancer with persistent left superior vena cava and left azygos vein: a case report
    Zhongben Tang
    Yin Teng
    Jian Li
    Xiaojun Du
    Jiarong Xiao
    Gongshun Tang
    Journal of Cardiothoracic Surgery, 15
  • [29] Left upper lung cancer with persistent left superior vena cava and left azygos vein: a case report
    Tang, Zhongben
    Teng, Yin
    Li, Jian
    Du, Xiaojun
    Xiao, Jiarong
    Tang, Gongshun
    JOURNAL OF CARDIOTHORACIC SURGERY, 2020, 15 (01)
  • [30] 10 Years Single Center Experience with Resection of the Superior Vena Cava in Locally Advanced Non-Small Cell Lung Cancer
    Hoda, M. A.
    Klikovits, T.
    Gschwandtner, E.
    Sinn, K.
    Hritcu, R.
    Klepetko, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S943 - S943